First Time Loading...

Heidelberg Pharma AG
XETRA:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
XETRA:HPHA
Watchlist
Price: 2.97 EUR Market Closed
Updated: May 19, 2024

Heidelberg Pharma AG
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Heidelberg Pharma AG
EPS (Diluted) Peer Comparison

Comparables:
BNTX
MOR
CVAC
IMTX
BIO

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Heidelberg Pharma AG
XETRA:HPHA
EPS (Diluted)
€0
CAGR 3-Years
10%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
EPS (Diluted)
€3
CAGR 3-Years
300%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
EPS (Diluted)
-€12
CAGR 3-Years
-31%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
EPS (Diluted)
-€1
CAGR 3-Years
-18%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
EPS (Diluted)
-€1
CAGR 3-Years
35%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
EPS (Diluted)
€3
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
18%

See Also

What is Heidelberg Pharma AG's EPS (Diluted)?
EPS (Diluted)
-0.4 EUR

Based on the financial report for Nov 30, 2023, Heidelberg Pharma AG's EPS (Diluted) amounts to -0.4 EUR.

What is Heidelberg Pharma AG's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-1%

Over the last year, the EPS (Diluted) growth was 17%. The average annual EPS (Diluted) growth rates for Heidelberg Pharma AG have been 10% over the past three years , -1% over the past five years .